Innovation
and Personalisation
of care for
hypercholesterolemia

 

 

Hypercholesterolemia :
it’s all about genes

 

 

Cardiovascular disease:
the number one cause
of death in France

 

 

Lowering LDL cholesterol
reduces the risk of cardiovascular events

 

Today in France, 1 person in every 300 suffers
from inherited hypercholesterolemia

 

The CHOPIN translational research project seeks to reduce cardiovascular risks
in patients by offering new personalised hypercholesterolemia treatment
 through the identification of new risk markers and therapeutic targets.

NEWS

See all the latest news

FOURIER study : we have to treat the LDL target

30/05/18
The FOURIER study has finally revealed its results ! The study yielded the positive result that the antibody...

Pilot treatment pathways in the Vendée and Loire-Atlantique for familial Hypercholesterolemia

30/05/18
Pilot treatment pathways in the Vendée and Loire-Atlantique for familial Hypercholesterolemia

Feedback on national familial hypercholesterolemia day

30/05/18
Anhet-f used world familial hypercholesterolemia day to bring its members together on 23 September 2017 in Paris.

Academic and Industry partners

Clinical trials over 5 years

Patients involved

million euros obtained via the RHU call for projects

 

COORDINATION :